Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus
Open Access
- 29 May 2023
- journal article
- research article
- Published by Elsevier in Military Medical Research
- Vol. 10 (1) , 1-19
Abstract
Continuous renal replacement therapy (CRRT) is widely used for treating critically-ill patients in the emergency department in China. Anticoagulant therapy is needed to prevent clotting in the extracorporeal circulation during CRRT. Regional citrate anticoagulation (RCA) has been shown to potentially be safer and more effective and is now recommended as the preferred anticoagulant method for CRRT. However, there is still a lack of unified standards for RCA management in the world, and there are many problems in using this method in clinical practice. The Emergency Medical Doctor Branch of the Chinese Medical Doctor Association (CMDA) organized a panel of domestic emergency medicine experts and international experts of CRRT to discuss RCA-related issues, including the advantages and disadvantages of RCA in CRRT anticoagulation, the principle of RCA, parameter settings for RCA, monitoring of RCA (mainly metabolic acid–base disorders), and special issues during RCA. Based on the latest available research evidence as well as the paneled experts’ clinical experience, considering the generalizability, suitability, and potential resource utilization, while also balancing clinical advantages and disadvantages, a total of 16 guideline recommendations were formed from the experts’ consensus.Keywords
This publication has 68 references indexed in Scilit:
- Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational studyCritical Care, 2012
- Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solutionCritical Care, 2012
- Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosisClinical Kidney Journal, 2012
- Quantification of Systemic Delivery of Substrates for Intermediate Metabolism during Citrate Anticoagulation of Continuous Renal Replacement TherapyBlood Purification, 2011
- Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unitClinical Kidney Journal, 2009
- Citrate anticoagulation for continuous venovenous hemofiltration*Critical Care Medicine, 2009
- Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous HemofiltrationAmerican Journal of Kidney Diseases, 2006
- Citrate Kinetics in Patients Receiving Long-Term Hemodialysis TherapyAmerican Journal of Kidney Diseases, 2005
- Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patientsCritical Care Medicine, 2003
- Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donationTransfusion, 2002